Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Dorenbaum

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Gastroenterology|January 7, 2018
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trialRenger G Tiessen, Ciara A Kennedy, Bradley T Keller, et al.
Anesthesiology|July 30, 2005
Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypassMark Stafford-Smith, Edward A Lefrak, Anjum G Qazi, et al.
The Journal of Infectious Diseases|July 23, 2002
Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316Coleen K Cunningham, Marie-Laure Chaix, Claire Rekacewicz, et al.
JAMA|July 4, 2002
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trialAlejandro Dorenbaum, Coleen K Cunningham, Richard D Gelber, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316D Heather Watts, Rajalakshmi Balasubramanian, Robert T Maupin, et al.
Lancet (London, England)|April 19, 2014
Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trialNicola Longo, Cary O Harding, Barbara K Burton, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
Hepatology Communications|March 13, 2019
A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary CholangitisMarlyn J Mayo, Paul J Pockros, David Jones, et al.
Hepatology Communications|May 15, 2023
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot studyChristopher L Bowlus, Bertus Eksteen, Angela C Cheung, et al.
Hepatology Communications|May 4, 2022
Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 studyKathleen M Loomes, Robert H Squires, Deirdre Kelly, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Gastroenterology|January 7, 2018
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trialRenger G Tiessen, Ciara A Kennedy, Bradley T Keller, et al.
Anesthesiology|July 30, 2005
Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypassMark Stafford-Smith, Edward A Lefrak, Anjum G Qazi, et al.
The Journal of Infectious Diseases|July 23, 2002
Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316Coleen K Cunningham, Marie-Laure Chaix, Claire Rekacewicz, et al.
JAMA|July 4, 2002
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trialAlejandro Dorenbaum, Coleen K Cunningham, Richard D Gelber, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316D Heather Watts, Rajalakshmi Balasubramanian, Robert T Maupin, et al.
Lancet (London, England)|April 19, 2014
Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trialNicola Longo, Cary O Harding, Barbara K Burton, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
Hepatology Communications|March 13, 2019
A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary CholangitisMarlyn J Mayo, Paul J Pockros, David Jones, et al.
Hepatology Communications|May 15, 2023
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot studyChristopher L Bowlus, Bertus Eksteen, Angela C Cheung, et al.
Hepatology Communications|May 4, 2022
Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 studyKathleen M Loomes, Robert H Squires, Deirdre Kelly, et al.
Pageof 3